Vir Biotechnology, Inc. (VIR)

10.75 +0.42 (+4.07%) USD  |  NASDAQ  |  Apr 17, 16:00
10.69 -0.06 (-0.56%) After-Hours: 06:46
More

Vir Biotechnology SG&A Expense (Quarterly) : 23.62M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for VIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Hims & Hers Health, Inc. 314.21M
BioMarin Pharmaceutical, Inc. 446.21M
Xeris Biopharma Holdings, Inc. 47.50M
Gossamer Bio, Inc. 10.90M
Sensei Biotherapeutics, Inc. 0.00